Intuitive Surgical Leverages Recurring Revenue Model to Drive Long-Term Growth

Intuitive Surgical (ISRG) is strengthening its market dominance in the robotic surgery sector, leveraging a growing installed base of da Vinci systems to create a sustainable growth flywheel. By the end of 2025, the company's global installation of robots surpassed 11,100 units, with over 20 million procedures performed to date using its systems. The company's financial strength is increasingly tied to its recurring revenue streams. Approximately 75% of total revenue is now derived from services, instruments, and accessories. This shift transforms the business from a primary hardware seller into a service-oriented healthcare provider, creating annuity-like income that scales as the installed base grows. Recent financial performance underscores this trajectory. In the fourth quarter of 2025, revenue grew 19% year-over-year, while adjusted earnings per share rose to $2.53 from $2.21 in the prior-year period. Furthermore, procedure growth in 2025 reached 18%, notably outpacing the 12% growth in new da Vinci system sales. Despite these strong fundamentals, the stock carries a significant premium valuation, trading at a price-to-earnings ratio of approximately 60x. This high multiple reflects aggressive growth expectations from the market, suggesting the stock is best suited for long-term investors capable of weathering short-term volatility in exchange for potential multi-decade expansion.